Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05095948 · ClinicalTrials.gov registry record
Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Not yet
- Registry status
- 200
- Enrollment target
NCT05095948: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT05095948 is a clinical trial that has not yet begun recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05095948 has not yet begun recruiting, sponsored by M.D. Anderson Cancer Center.
- NOT YET RECRUITING
- Registry status
- 200 participants
- Enrollment target
Study Summary
This study examines how cancer care is delivered in oncology and supportive care clinics. Collecting patient feedback may help doctors better understand the processes of cancer care in oncology and supportive care clinics.
Primary Outcome
Will be examined using linear mixed models (LMMs) with physician as the unit of analysis.
Interventions
- OTHER Questionnaire Administration
- OTHER Electronic Health Record Review
- PROCEDURE Discussion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-08-30 |
| Est. Completion | 2026-09-30 |
What is known before NCT05095948 opens enrollment
NCT05095948 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT05095948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05095948 about?
NCT05095948 is a clinical study titled "Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center". This study examines how cancer care is delivered in oncology and supportive care clinics. Collecting patient feedback may help doctors better understand the processes of cancer care in oncology and supportive care clinics.
What is the current status of trial NCT05095948?
This trial is currently not yet recruiting. The enrollment target is 200 participants. The study started on 2026-08-30. Estimated completion is 2026-09-30.
What interventions are being tested in trial NCT05095948?
The interventions under investigation include: Questionnaire Administration (OTHER), Electronic Health Record Review (OTHER), Discussion (PROCEDURE).
Who is sponsoring clinical trial NCT05095948?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI